BMO Capital analyst Jeffrey Silber maintained a Buy rating on Adtalem Global Education (ATGE – Research Report) on May 9 and set a price target of $132.00.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Jeffrey Silber has given his Buy rating due to a combination of factors that highlight Adtalem Global Education’s strong performance and promising outlook. The company has shown impressive enrollment growth, exceeding expectations with a 9.8% increase, which has significantly contributed to revenue and margin expansion. This growth is evident across various programs, including both pre-licensure and post-licensure nursing programs, as well as in the medical and veterinary segments.
Moreover, Adtalem’s financial health is robust, as demonstrated by its ability to repay high-interest debt and complete a substantial share repurchase program. The company has also raised its guidance for fiscal year 2025, indicating confidence in continued operational efficiencies and margin improvements. These factors, combined with a strategic focus on the medical and healthcare sectors, which are expected to outperform the broader industry, underpin Silber’s positive outlook and Buy rating for the stock.
In another report released on May 9, Barrington also reiterated a Buy rating on the stock with a $140.00 price target.
Based on the recent corporate insider activity of 74 insiders, corporate insider sentiment is neutral on the stock.